Some Wall Street analysts said Viking's experimental obesity treatment may be "best-in-class" following the release of midstage trial data.
Source: https://www.cnbc.com/2024/03/03/weight- ... titor.html
Viking Therapeutics emerges as a strong weight loss drug player — or takeover target
